Skip to main content
. 2023 Sep 18;10(6):3472–3482. doi: 10.1002/ehf2.14510

Table 4.

Outcome according to the cardiogenic shock aetiology

Overall cohort AMI‐CS ADHF‐CS P value
(N = 190) (N = 101) (N = 89)
In‐hospital mortality 78 (41.1) 39 (38.6) 39 (43.8) 0.5
Mortality at last available follow‐up a 85 (44.7) 44 (43.6) 41 (46.1) 0.7
LVAD 11 (6.0) 2 (2.0) 9 (11.0) 0.01
Heart transplantation 12 (6.3) 0 (0.0) 12 (13.5) <0.001
Bleeding events during hospital stay b 28 (14.7) 13 (13.9) 14 (15.7) 0.7
BARC minor (<3b) 9 (33.3) 4 (30.8) 5 (35.7)
BARC major (≥3b) 18 (66.7) 9 (69.2) 9 (64.3)
Follow‐up after discharge, days median (IQR) c 56 (0–200) 56 (0–200) 49 (5–218) 0.8
Re‐hospitalization c 28 (25.5) 19 (31.6) 9 (18.0) 0.1
30 days re‐hospitalization c 11 (10.0) 8 (13.3) 3 (6.0) 0.2

Data are presented as n (%).

ADHF, acute decompensated heart failure; AMI, acute myocardial infarction; BARC, Bleeding Academic Research Consortium; CS, cardiogenic shock; IQR, interquartile range; LVAD, left ventricular assist device.

a

Median last available follow‐up of 36 days (interquartile range 14–110).

b

Missing data on details on bleeding type according to BARC for one patient in AMI‐CS group. Percentages are presented on available data.

c

Among patients survived after index event with available data (110 patients: 60 in AMI‐CS and 50 ADHF‐CS).